The DOI matches its Crossref record; 80 of the 84 references it cites were found in a registry or an index.
A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
Open accessAbstract
Unlabelled The Food and Drug Administration (FDA), Substance Abuse and Mental Health Services Administration (SAMHSA), and the National Institute for Drug Abuse (NIDA) report that no sound scientific studies support the medicinal use of cannabis. Despite this lack of scientific validation, many patients routinely use "medical marijuana," and in many cases this use is for pain related to nerve injury. We conducted a double-blinded, placebo-controlled, crossover study evaluating the analgesic efficacy of smoking cannabis for neuropathic pain. Thirty-eight patients with central and peripheral neuropathic pain underwent a standardized procedure for smoking either high-dose (7%), low-dose (3.5%), or placebo cannabis. In addition to the primary outcome of pain intensity, secondary outcome measures included evoked pain using heat-pain threshold, sensitivity to light touch, psychoactive side effects, and neuropsychological performance. A mixed linear model demonstrated an analgesic response to smoking cannabis. No effect on evoked pain was seen. Psychoactive effects were minimal and well-tolerated, with some acute cognitive effects, particularly with memory, at higher doses.Perspective This study adds to a growing body of evidence that cannabis may be effective at ameliorating neuropathic pain, and may be an alternative for patients who do not respond to, or cannot tolerate, other drugs. However, the use of marijuana as medicine may be limited by its method of administration (smoking) and modest acute cognitive effects, particularly at higher doses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Seven studies assessed CBM use on appetite in participants experiencing chronic pain, including two RCTs,59,63 two cross-sectional studies,79,88 two case series,91,92 and one pre-post study.70”
From Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions (2024) · cites this paper as [63]
In the citing paper
“This study reported that cannabinoids compounded the decreased neurocognitive performance of patients that was present at baseline.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [155]
In the citing paper
“Smoking cannabis cigarettes also improved spontaneous pain relief and pain unpleasantness VAS ratings in patients suffering from mixed forms of neuropathic pain, but failed to alter stimulus-evoked pain.155”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [155]
Citations
Cites
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Berti, A. (1992) · Neuropsychologia · doi:10.1016/0028-3932(92)90076-x · Cited by 4,190
Wechsler Adult Intelligence Scale--Third Edition
Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
International Association for the Study of Pain
Breivik, H. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00465-7 · Cited by 1,222
Development and preliminary validation of a pain measure specific to neuropathic pain
Galer, B. S., & Jensen, M. (1997) · Neurology · doi:10.1212/wnl.48.2.332 · Cited by 778
Horton, A. M., & Moses, J. A. (1996) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/11.8.713 · Cited by 765
Flagged first, then by citations
4 of the 84 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Ad Hoc Group of Experts, Report to the Director, National Institutes of Health: Workshop on the Medical Utility of Marijuana, February 19-20, 1997
- Bostrom, 2005, Gonzales v Raich, Issues Law Med, 21, 47
- Gieringer, 1996, Marijuana research: Waterpipe study, MAPS (Multidisciplinary Association for Psychedelic Studies) Bull, 6, 59
- Schnelle, 1999, Results of a standardized survey on the medical use of cannabis products in the German-speaking area, Forsch Komplementarmed, 6, 28
Cited by
Sorted by citations
Items 201–300 of 327
Cunningham, C. O., Starrels, J. L., Zhang, C., Bachhuber, M. A., Sohler, N., LEVIN, F. R., Minami, H., Slawek, D. E., & Arnsten, J. H. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043400 · Cited by 12
Medical and recreational marijuana: commentary and review of the literature.
Wilkinson, S. T. (2013) · Europe PMC (PubMed Central) · Cited by 13
Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 12
Considering Marijuana Legalization
Caulkins, J. P., Kilmer, B., R.Kleiman, M. A., MacCoun, R. J., Midgette, G., Oglesby, P., Pacula, R. L., & Reuter, P. (2015) · Cited by 11
Gunasekera, B., Davies, C., Blest-Hopley, G., Veronese, M., Ramsey, N. F., Bossong, M. G., Radua, J., Bhattacharyya, S., Pretzsch, C., McAlonan, G., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104801 · Cited by 10
Medical Cannabis in Hand Surgery: A Review of the Current Evidence
Yang, A., Townsend, C. B., & Ilyas, A. M. (2023) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2022.11.008 · Cited by 10
Moshfeghinia, R., Najibi, A., Moradi, M., Assadian, K., & Ahmadi, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1438002 · Cited by 13
Are Cannabis-Based Medicines a Useful Treatment for Neuropathic Pain? A Systematic Review
Almuntashiri, N., Sharazly, B. M. E., & Carter, W. G. (2025) · Biomolecules · doi:10.3390/biom15060816 · Cited by 10
“A comparison of low-dose (3.5% ∆ 9 -THC) and high-dose (7% ∆ 9 -THC) vaporized cannabis cigarettes reported that both doses provided statistically significant pain relief compared to placebo, but without significant differences in analgesia between the treatment groups [43].”
InfluentialBachhuber, M. A., Arnsten, J. H., Starrels, J. L., & Cunningham, C. O. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0051 · Cited by 9
Role of Cannabinoids in Pain Management
Halawa, O. I., Furnish, T. J., & Wallace, M. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00056-5 · Cited by 10
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain
McDonagh, M. S., Wagner, J., Ahmed, A. Y., Fu, R. F., Morasco, B. J., Kansagara, D. L., & Chou, R. (2021) · doi:10.23970/ahrqepccer250 · Cited by 10
Fijał, K., & Filip, M. (2016) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000132 · Cited by 10
Hout, M. V., Collins, C., Delargy, Í., & Crowley, D. (2017) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-016-9710-2 · Cited by 8
“…are reported to use cannabis for pain management and psychological support (Clark et al. 2004; Joy et al. 1999), despite smoking being a crude delivery system for the relief of posttraumatic, peripheral and HIV neuropathic pain (Ellis et al. 2009; Ware et al. 2003, 2010; Wilsey et al. 2008).”
Why Insurance Companies Should Pay for Medical Cannabis
Casarett, D., & Abrams, D. I. (2019) · The American Journal of Bioethics · doi:10.1080/15265161.2019.1567193 · Cited by 11
Tsai, S. H. L., Lin, C.-R., Shao, S., Fang, C.-H., Fu, T., Lin, T., & Hung, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.866235 · Cited by 9
“Two studies contained two intervention groups, including that byWilsey et al. (Wilsey et al., 2008) (high and low dose THC) and Berman et al. (Berman et al., 2004) (THC and nabiximols).”
InfluentialCannabis-based medicines for chronic neuropathic pain in adults
Ateş, G., Welsch, P., Klose, P., Phillips, T., Lambers, B., Häuser, W., & Radbruch, L. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182.pub3 · Cited by 11
Pharmacy students’ knowledge and attitudes regarding cannabis for medical purposes
Stojanovic, M., Tomás, A., Kusturica, M. P., Rašković, A., Ubavic, M., Tomić, Z., Sabo, A., & Horvat, O. (2017) · Hospital Pharmacology - International Multidisciplinary Journal · doi:10.5937/hpimj1703559s · Cited by 9
“Research studies demonstrate some benefi ts for the use of medical marijuana for conditions such as severe nausea and vomiting, glaucoma, anorexia, chronic pain, and spasticity related to diseases such as multiple sclerosis [4-8].”
The Development of Cannabinoids as Therapeutic Agents in the United States
Murray, C. H., Gannon, B. M., Winsauer, P. J., Cooper, Z. D., & Delatte, M. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001121 · Cited by 10
Clemens, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00023-x · Cited by 8
Current Status and Future of Cannabis Research
Russo, E. B., Mead, A., & Sulak, D. (2015) · doi:10.14524/cr-15-0004 · Cited by 8
Linden‐Carmichael, A. N., Allen, H. K., Masters, L. D., Ansell, E. B., & Lanza, S. T. (2020) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2020.1831003 · Cited by 8
Nouh, R. A., Kamal, A., Oyewole, O., Abbas, W. A., Abib, B., Omar, A., Mansour, S. T., & Abdelnaser, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020241 · Cited by 11
Cannabis for Symptom Control #279
Aggarwal, S. K., & Blinderman, C. D. (2014) · Journal of Palliative Medicine · doi:10.1089/jpm.2014.9431 · Cited by 8
Choi, J., Li, G., Stephens, K. L., Timko, M. P., & DeGeorge, B. R. (2024) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2024.09.015 · Cited by 7
Alayoubi, M., Henry, B. A., Cahill, C. M., & Cooper, Z. D. (2024) · Drugs · doi:10.1007/s40265-024-02098-1 · Cited by 7
Starrels, J. L., Young, S. R., Azari, S., Becker, W. C., Edelman, E. J., Liebschutz, J. M., Pomeranz, J. L., Roy, P. J., Saini, S., & Merlin, J. S. (2019) · Pain Medicine · doi:10.1093/pm/pnz153 · Cited by 7
Cannabinoid-Based Drugs: Potential Applications in Addiction and Other Mental Disorders
Don, W., & Piomelli, D. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20150009 · Cited by 7
Grant, I., Atkinson, J. H., & Gouaux, B. D. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12060791 · Cited by 7
Therapeutic uses of Cannabis sativa L. Current state and future perspectives
Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89867-6.00010-x · Cited by 6
Should doctors be allowed to prescribe cannabinoids for pain in Australia and New Zealand?
Shipton, E. A., & Shipton, E. E. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413520048 · Cited by 6
Reyes, M. F., & Khenti, A. (2019) · Texto & Contexto - Enfermagem · doi:10.1590/1980-265x-tce-cicad-15-8 · Cited by 6
Sustained cannabis use does not predispose clinical hypertension: Findings from a national survey
Shah, R. M., Patel, S., Shah, S., Doshi, S., Li, A., & Diamond, J. A. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14623 · Cited by 6
Current State of Pain Treatment in Oriental Medicine
Park, J., Jung, H., Kim, A., Jung, S., Hwang, H. S., & Choi, S. (2011) · Cited by 6
Medicinal Plants for the Treatment of Neuropathic Pain: A Review of Randomized Controlled Trials
Ahmadzadeh, A. M., Pourali, G., Mirheidari, S. B., Shirazinia, M., Hamedi, M., Mehri, A., Amirbeik, H., Saghebdoust, S., Tayarani‐Najaran, Z., Sathyapalan, T., et al. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230714143538 · Cited by 5
More evidence cannabis can help in neuropathic pain
McQuay, H. J. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100799 · Cited by 5
Workman, C. D., Kindred, J. H., Ponto, L. L. B., Kamholz, J. A., & Rudroff, T. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0634 · Cited by 6
Medicinal Cannabis and Painful Sensory Neuropathy
Grant, I. (2013) · The AMA Journal of Ethic · doi:10.1001/virtualmentor.2013.15.5.oped1-1305 · Cited by 5
Rudroff, T., Workman, C. D., Gander, P. E., Deters, J. R., & Ponto, L. L. B. (2022) · Brain Sciences · doi:10.3390/brainsci12070819 · Cited by 4
Büntzel, J., Micke, O., & Büntzel, J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03415-3 · Cited by 4
Cannabinoid-Related Adverse Events and Impairment
MacCallum, C. A., de Freitas, L., Lo, L. A., Eadie, L., & Brubacher, J. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_36 · Cited by 4
Wallace, M. S., & Ware, M. A. (2015) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000217 · Cited by 4
Aragon, F., Lozada, M., Bigatti, G., González‐José, R., Kochen, S. S., & McCarthy, I. (2025) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2025.2517778 · Cited by 3
Cannabinoids in pain and palliative care medicine – hope or dope?
Kraft, B., & Kress, H. G. (2009) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-009-0148-0 · Cited by 2
Cannabinoids: Drug or Medication?
Giron, L., & Befort, K. (2016) · InTech eBooks · doi:10.5772/63172 · Cited by 4
“This study showed that cannabis is effective at ameliorating neuropathic pain [41].”
Campbell, N. K. J. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.1150111 · Cited by 3
TIBBİ KENEVİR VE SAĞLIK: FARMAKOLOJİK BİR DERLEME
Balpınar, Ö., & Aytaç, S. (2021) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.859372 · Cited by 3
Cannabinoids for the Treatment of Chronic Pain: A Critical Review of Randomized Controlled Trials
Hassan, S. I. (2018) · Journal of Pain Management & Medicine · doi:10.35248/2684-1320.18.4.131 · Cited by 4
“Yet these options have always been associated with either significant side effects or insignificant efficacy on the long run [7].”
Use of cannabis in medicine and pharmacy
Goločorbin-Kon, S., Pavlović, N., Rašković, A., Lalic-Popovic, M. N., Milić, N., Milosevic, N. P., & Mikov, M. (2015) · Medicinski casopis · doi:10.5937/mckg49-9796 · Cited by 3
“Krajem prve dekade XXI veka istraživači sa Univerziteta u Kaliforniji objavili su rezultate kliničkog ispitivanja koje pokazuje da i visoke i niske doze udahnutog kanabisa smanjuju neuropatski bol različitog porekla kod osoba koje ne reaguju na standardnu terapiju bola (23).”
The medical geography of cannabinoid botanicals in Washington State: Access, delivery, and distress
Aggarwal, S. K. (2008) · ProQuest Demo Repository · Cited by 3
Cannabis and the Lung: No More Smoking Gun?
Ware, M. A. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201302-034ed · Cited by 3
Why conscientious objection merits respect
Goligher, E. C., Sorbo, L. D., Cheung, A. M., Alibhai, S. M. H., Liao, L., Easson, A. M., Halpern, J., Ely, E. W., Sulmasy, D. P., & Hwang, S. W. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.1150113 · Cited by 3
Shah, D., Murhekar, S., Ward, M., Sagane, S., & Pahwani, A. (2025) · Cureus · doi:10.7759/cureus.87208 · Cited by 2
“For example, Wilsey et al. (2008) using high-dose cannabis (7% THC) showed a significant reduction in pain, contrasting with lower THC 16 concentrations in other studies that reported lesser pain reduction [49].”
Tang, R., Gong, C.-Y., Liu, Y., Wang, Y.-B., & Zhou, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1656400 · Cited by 2
Cannabis and Cannabinoids (PDQ
Integrative, P. (2011) · Cited by 2
Marijuana and Cannabinoids for Pain
Furnish, T. J., & Wallace, M. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-30964-4_7 · Cited by 2
What Steps Should be Taken to Integrate Marijuana into Pain Regimens?
Wallace, M. S., & Furnish, T. J. (2015) · Pain Management · doi:10.2217/pmt.15.20 · Cited by 2
Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?
Malcolm, B., Murphy, L. L., & (Con), M. W. (2018) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v71i3.2588 · Cited by 2
Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis
Hoch, E., Schneider, M., von Keller, R., Bonnet, U., Falkai, P., Hasan, A., Häuser, W., Hinz, B., Jakob, L., Kabisch, J., et al. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_4 · Cited by 2
Medical Marijuana for Chronic Pain
Hall, B. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-47117-0_14 · Cited by 2
Evaluation and Treatment Of Pain With Medicinal Cannabis
Dalal, R., & Kudur, V. (2021) · StatPearls · Cited by 2
Muresanu, D. F., Roșu, O. V., Bîrle, C., Popa, L. L., Chira, D., Strilciuc, Ș., & Buzoianu, A. D. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_431-1 · Cited by 2
Muresanu, D. F., Roșu, O. V., Bîrle, C., Popa, L. L., Chira, D., Strilciuc, Ș., & Buzoianu, A. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_431 · Cited by 2
Grant, I. (2015) · JAMA · doi:10.1001/jama.2015.11429 · Cited by 2
Chou, R., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., Selph, S., Holmes, R. S., & Fu, R. (2022) · doi:10.23970/ahrqepccannabissurveillance4 · Cited by 1
Cannabis Compounds: Potential Therapy for Neurological Disease
Babayeva, M., & Loewy, Z. G. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005770 · Cited by 1
Budnik, J. V. H., Higgins, T. F., Malfait, A., Weinrich, J. A. P., Basbaum, A. I., Hsu, J. R., Morshed, S., & Bahney, C. S. (2025) · OTA International The Open Access Journal of Orthopaedic Trauma · doi:10.1097/oi9.0000000000000352 · Cited by 1
Standardized Cannabis and Pain Management
Paul, A. (2012) · InTech eBooks · doi:10.5772/29385 · Cited by 1
The Management of Neuropathic Pain
Toth, C., & Moulin, D. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.019 · Cited by 1
Xifró, X., Puig, T., & Boadas‐Vaello, P. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.09.014 · Cited by 1
OP-ED Medicinal Cannabis and Painful Sensory Neuropathy
Md, I. G. (2013) · Cited by 1
The Legalization of Marijuana in Colorado: A Prescription for Trouble?
Gundersen, D. C. (2015) · Journal of Medical Regulation · doi:10.30770/2572-1852-101.1.8 · Cited by 1
Appendix B: Quality Research, Evidence of Effectiveness of Medical Cannabis
(2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30099-1 · Cited by 1
Pharmacokinetics and Cognitive Side Effcets of Cannabidiol In Adult Patients
Mote, M. A. N., Bhise, M. P. B., Chavan, M. R. D., Patil, M. P. P., & Kengar, M. D. (2022) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-7676 · Cited by 1
Somboonwit, C., Rutenburg, D., Oxner, A. Z., & Menezes, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-57369-9_9 · Cited by 1
Renard, O., Corbin, S., Drouet, Y., Lasset, C., & Chvetzoff, G. (2019) · Douleur et Analgésie · doi:10.3166/dea-2019-0059 · Cited by 1
PERCEPTION OF HARM AND BENEFITS OF CANNABIS USE AMONG ADOLESCENTS FROM LATIN AMERICA AND CARIBE
Conceição, M. I. G., Reyes, M. F., Henríquez, P., Modeste, N., Wynter, J., Gray‐Phillip, G., Tavarez, G. G., Husaini, D. C., Morgado, M., Rivera-Fierro, K., et al. (2019) · Texto & Contexto - Enfermagem · doi:10.1590/1980-265x-tce-cicad-12-24 · Cited by 1
McDonagh, M. S., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Chou, R. (2021) · doi:10.23970/ahrqepccerplantpain3 · Cited by 1
Cannabinoids and Pain: Clinical Evidence
MacCallum, C. A., Eadie, L., & Narouze, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_25 · Cited by 1
Canavero, S., & Bonicalzi, V. (2018) · Springer eBooks · doi:10.1007/978-3-319-56765-5_17 · Cited by 1
Targeting the Endocannabinoid Metabolic Enzymes to Reduce Inflammatory Pain
Ghosh, S. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/ngv2-th75 · Cited by 1
“…and postsurgical neuropathic pain, central peripheral neuropathic pain, human immunodeficiency virus–associated sensory neuropathy and cisplatin-induced pain and hyperalgesia (Abrams et al., 2007, Ellis et al., 2009, Fiz et al., 2011, Wallace et al., 2007, Ware et al., 2010, Wilsey et al., 2008).”
Temple, E. C. (2014) · Addiction · doi:10.1111/add.12580 · Cited by 1
“[3]); in comparison, van der Pol et al.”
Chou, R., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Selph, S. (2022) · doi:10.23970/ahrqepccannabissurveillance3 · Cited by 1
Protocolo diagnóstico y terapéutico del dolor neuropático
Brou, M. P. A., Palomo, M. J. S., & Izquierdo, A. Y. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70087-7
Review: short-term medical use of cannabis increases risk of non-serious adverse effectsCommentary
Esson, L. (2008) · Evidence-Based Nursing · doi:10.1136/ebn.12.1.16
O’Connell, N. (2008) · Nurse Prescribing · doi:10.12968/npre.2008.6.6.29607
Prescrire du cannabis fumé pour la douleur chronique non cancéreuse: Recommandations préliminaires
Kahan, M., Srivastava, A., Spithoff, S. M., & Bromley, L. A. (2014) · Europe PMC (PubMed Central)
Cannabinoid modulation of nociception and nociceptor activity during inflammation.
Potenzieri, C. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Ethics of Pain Measurement and Management From the Editor Ethical Perspectives on Pain
Kumar, B. P., Berger, J. M., & Vadivelu, N. (2013)
Cranford, J. A., & Cooper, D. (2015) · F1000Research · doi:10.12688/f1000research.7472.1
Ware, M. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.022
The Yin and Yang of clinical decision making before prescribing medical marijuana
Cirone, S., Dubin, R. E., Kahan, M., & Montgomery, L. S. (2014)
Dahmer, S., & Kligler, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00019-0
Cannabis and Medicinal Properties.
Madras, B. K. (2016) · PubMed
Maher, D. P., Shah, B. J., & Vorobeychik, Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_19 · Cited by 1
Physicians' Perspectives on Medical Cannabis in Norway: A Cross-Sectional Study
Arnfinsen, J. L. (2018) · NORA - Norwegian Open Research Archives
Cannabis in Palliative Medicine
Saint-Preux, F., Arora, A., Moriyama, D., Kim, E., & Kim, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_13
Metadata
- Authors
- Wilsey, B., Marcotte, T., Tsodikov, A., Millman, J., Bentley, H., Gouaux, B., & Fishman, S.
- Affiliations
- VA Northern California Health Care System (US)
- University of California San Diego (US)
- University of California Davis Medical Center (US)
- Corresponding author
- Wilsey, Barth
- Venue
- The Journal of Pain
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 9
- Issue
- 6
- Pages
- 506-521
- ISSN
- 1526-5900 (ISSN-L)
- PMC
- PMC4968043
- OpenAlex
- W2133895281
- Cited by
- 327
- References
- 84
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 13 · 2023: 11 · 2022: 19 · 2021: 20 · 2020: 25 · 2019: 30 · 2018: 34 · 2017: 23 · 2016: 20 · 2015: 27 · 2014: 22 · 2013: 19 · 2012: 12
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000002)
- National Institute on Drug Abuse
- National Center for Research Resources (UL1RR024146)
- National Center for Advancing Translational Sciences
- Center for Medicinal Cannabis Research, University of California, San Diego
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- cannabis, neuropathic pain, medical cannabis, analgesic efficacy, pain intensity, evoked pain, psychoactive effects, cognitive effects, memory, dose-response relationship, central pain, peripheral neuropathic pain
- MeSH terms
- Adult, Affect, Aged, Cannabinoids, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Marijuana Smoking, Middle Aged, Neuralgia, Neuropsychological Tests, Pain Measurement, Time Factors, Linear Models, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review